Low dose oral methotrexate treatment of multiple sclerosis: a pilot study
R D Currier, A F Haerer, E F Meydrech, R D Currier, A F Haerer, E F Meydrech
Abstract
An 18-month double-blind treatment of multiple sclerosis with low dose oral methotrexate showed it to be well tolerated and suggested effectiveness in exacerbating-remitting MS but not in the exacerbating progressive and chronic progressive stages.
References
- Neurology. 1972 Dec;22(12):1268-71
- Neurology. 1955 Aug;5(8):580-3
Source: PubMed